Inte:Ligand illustration

Company

Scientific Advisory Board

We are proud to introduce the members of our scientific advisory board: Prof. Dr. Gerd Folkers, Prof. Dr. Marcel Hibert, Prof. Dr. Hugo Kubinyi, Prof. Dr. Thierry Langer, and Prof. DDr. Klaus Liedl.

Prof. Dr. Gerd Folkers

Gerd Folkers has been Full Professor of Pharmaceutical Chemistry at ETH Zurich since 1994 and is the Chair of the Collegium Helveticum since 2004. After he finished his pharmacy studies at Bonn University (1978) he obtained a Ph.D. in 1980. In 1989 he was nominated as Dozent and since 1991 he is full professor at the ETH Zurich. He was guest professor at the University of Napoli (Italy) and at the SISSA in Triest (Italy). Prof. Folkers is member of the scientific advisory board of several companies. His research interests are focused on computer-aided modeling and prediction of molecular interactions, on spectroscopical, biophysical, immunological and molecular biological methods for the testing modeling studies, and on quantum chemistry techniques in drug design.

[top of the page]

Prof. Dr. Marcel Hibert

Dr. Marcel Hibert is full professor for organic chemistry at the Faculty of Pharmacy at the Université Louis Pasteur in Strasbourg (France). After his Ph.D. (1981) in organic chemistry he started to work in the Marion Merrell Dow Research Center, Strasbourg. In 1992 he was nominated as head of the department "Receptor Chemistry and Molecular Modeling". In 1996 he was promoted "Director of Chemistry and Structural Biology" and became member of the board of directors. Since 1997 he is professor at the Université Louis Pasteur in Strasbourg. His main interests are focused on organic chemistry, combinatorial chemistry, molecular modeling, drug design, and research management.

[top of the page]

Prof. Dr. Hugo Kubinyi

Dr. Hugo Kubinyi was head of the department of drug design, molecular modelling and protein crystallography in the Life Sciences Research Center (Hauptlaboratorium) of BASF AG, Ludwigshafen. He retired in June 2001. Since 1998 he was also responsible for the Combinatorial Chemistry activities of BASF AG. After his Ph.D. thesis at the Max Planck Institute of Biochemistry, Munich, and a Postdoc position at the Biochemical Institute of the German Cancer Research Center, Heidelberg, he joined the Research Department of the pharmaceutical company KNOLL AG, Ludwigshafen, in 1966. In 1985 he moved to BASF AG. After his habilitation in 1978 he was nominated in 1986 as professor of pharmaceutical chemistry at the Faculty of Pharmacy of the University of Heidelberg. From 1993-2000 he was Deputy Chair of the Scientific Advisory Board of GMD, the German National Center of Information Technology, and from 1995-2000 he was Chair of the QSAR and Modelling Society (740 members, worldwide).

His fields of research are structure-activity relationships, molecular modelling, and rational drug design.

[top of the page]

Prof. Dr. Thierry Langer

Dr. Thierry Langer is full professor for pharmaceutical chemistry at the Faculty of Life Scieces at University of Vienna, Austria. After his pharmacy M.S. degree (1987) he obtained a Ph.D. degree from the University of Vienna (Austria) in 1991. He then spent one year as a Schroedinger post-doc fellow at the University Louis Pasteur (Strasbourg, France) with Prof. C.-G. Wermuth. In 1992 he moved to the University of Innsbruck, where he created the Computer Aided Molecular Design Group. In 2003, he co-founded Inte:Ligand GmbH and acted as CEO until 2008. From 2008 to 2013 he was CEO of Prestwick Chemical in France. Prof. Langer is a well known scientist in the field of computer aided molecular design: His scientific work has culminated in more than 170 original articles and invited reviews in peer reviewed journals, several book chapters, one edited book, and more than 220 presentations at scientific meetings.

His main research interests are focused on theoretical pharmaceutical chemistry, drug design, and pharmacophore elucidation using molecular modeling techniques as well as QSAR and 3D-QSAR.

[top of the page]

Prof. DDr. Klaus Liedl

Prof. DDr. Klaus R. Liedl is head of a research group at the Center of Molecular Biosciences at the Faculty of Chemistry and Pharmacy, University of Innsbruck. After he finished his chemistry and mathematics studies (Innsbruck 1989, 1992), he studied theoretical physics and obtained a Ph.D. in chemistry (1995). Since 1998 he is tenured associate professor for theoretical chemistry. In 1998 he obtained the Novartis research award, in 2002 the Hellmann award of AG Theoretical Chemistry (German Bunsen Society, DPG, GDCh). In 2000 he became member of Scientia Europaea (French academy of sciences, Aventis). He was head of the Institute of General, Inorganic and Theoretical Chemistry in 2003 and 2004. 2006 he finished his doctorate in juridical science focusing on intellectual property rights complementing his chemical research as proven by his more than 100 publications in the field.

His main research interests are focused on drug development, the understanding and prediction of kinetics and thermodynamics in the course of biomolecular binding processes and reactions.

[top of the page]

Contact · Disclaimer

© Inte:Ligand GmbH / s3